ACLARION, INC. Adjustments to Additional Paid in Capital, Warrant Issued
ACLARION, INC. (ACON) reported Adjustments to Additional Paid in Capital, Warrant Issued of $336.44 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-08-06
- ACLARION, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-03-31 was $336.44K.
- ACLARION, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-09-30 was $22.50K.
- ACLARION, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-06-30 was $37.50K, a 2829.69% increase year-over-year.
- ACLARION, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2022-12-31 was $0.00.
- ACLARION, INC. adjustments to additional paid in capital, warrant issued for fiscal 2022 was $1.28K, a 95.79% decline from fiscal 2021.
- ACLARION, INC. adjustments to additional paid in capital, warrant issued for fiscal 2021 was $30.39K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2025-03-31 | $336.44K 10-Q · filed 2026-08-06 | |||
| 2023-09-30 | $22.50K 10-Q · filed 2023-11-14 | $60.00K derived: sum of 2 quarters · filed 2023-11-14 | ||
| 2023-06-30 | $37.50K 10-Q · filed 2023-11-14 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $1.28K 10-K · filed 2024-03-28 | ||
| 2022-09-30 | $1.28K 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | $1.28K 10-Q · filed 2023-11-14 | |||
| 2021-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-12 | $30.39K 10-K/A · filed 2023-06-12 | ||
| 2021-09-30 | $30.39K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |